Skip to main content
. Author manuscript; available in PMC: 2010 Apr 8.
Published in final edited form as: Circ Cardiovasc Genet. 2009 Dec 3;3(1):22–30. doi: 10.1161/CIRCGENETICS.109.862748

Table 4.

The Subsamples of Men (n=2772, I=115) Defined by the Step 1 PRIM Analysis

Subsample, n (%) Cumulative Incidence (95% CI) Description Subgroup, n (%)
MS 1, 234 (8.4) I=209 (185, 273) Age ≥65 y and HDL-C <40 mg/dL 234 (8.4)
MS 2, 741 (26.7) I=189 (171, 248) Age ≥65 y and HDL-C ≥40 mg/dL and HYT 741 (26.7)
MS 3, 99 (3.6) I=192 (123, 296) Age ≥ 65 y and HDL-C ≥ 40 mg/dL and DIAB and (ε33 or ε42 or ε43 or ε44) and no HYT 10 (0.4)
Or
Age 45 to 64 y and DIAB and (ε33 or ε42 or ε43 or ε 44) 89 (3.2)
MS 4, 1698 (61.3) I=65 (54, 77) Age ≥65 y and HDL-C >40 mg/dL and no HYT and [no DIAB and/or (ε22 or ε32)] 213 (7.7)
Or
Age 45 to 64 y and no DIAB and/or (ε22 or ε32) 1485 (53.6)

I indicates number of cases/1000 individuals at risk; HYT, history of hypertension; DIAB, history of diabetes; SMK, history of smoking.